Chardan Capital Markets
Chardan Capital Markets

Chardan Capital Markets

DR30Ahrefs DR: 30/100. Below median. Measured by Ahrefs. Median 44.

Chardan is an independent, full-service global investment bank focused on healthcare, disruptive technologies, and SPACs.

Website
20028 portfolio$10.5B AUMNew York City, USA

About

Chardan is an independent, full-service global investment bank that supports the capital markets goals of corporate and institutional clients. The firm specializes in healthcare, disruptive technologies, and special-purpose acquisition companies (SPACs). Chardan provides M&A advisory, capital raising, financial restructuring, and fairness opinions services.

Key facts

At-a-glance profile data

Website
chardan.com
Headquarters
New York City, USA
Funds raised
$10.5B
Portfolio companies
8
Stages
Seed
Early-Stage
IPO
Post-IPO
Series A
Sector focus
Healthcare
Biotech
Disruptive Technologies
Digital Assets
Fintech

Recent investments

Recent funding rounds Chardan Capital Markets took part in
DateCompanyRoundAmount
16 Jun 2021FemasysIPO$34M
Add first review

Frequently asked

What companies has Chardan Capital Markets invested in?

Chardan Capital Markets has invested in Femasys, Passage Bio, Log in, Ccm Qa, Femasys Inc. and 3 more.

Founders (1)
SU
Steven Urbach
Co-Founder and CEO

Find a founder email